Dexcom stock price trading at $125

Trading at $125.90, Dexcom’s stock is outperforming the NASDAQ healthcare index year-to-date. Momentum models suggest further room for upside if macro conditions stay favorable. Some firms, like J.P. Morgan, have reiterated an overweight rating and recently raised their price target to $112. These analysts highlight the current stock levels as an attractive opportunity, given DexCom’s guidance and execution quality, while acknowledging some near-term valuation risks. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy DexCom? Access our full analysis report here, it’s free . Dexcom stock price hovered at $122.90 in mid-day trading, supported by increasing institutional accumulation. Technical indicators such as the 50-day SMA crossing above the 200-day SMA suggest bullish momentum in the near-to-mid term.